Stereotyped B-Cell Receptor Immunoglobulins in B-Cell Lymphomas
- 19 October 2024
- book chapter
- Published by Springer Nature
- Vol. 2865, 125-143
Abstract
Thorough examination of clonotypic B-cell receptor immunoglobulin (BcR IG) gene rearrangement sequences in patients with mature B-cell malignancies has revealed significant repertoire restrictions, leading to the identification of subsets of patients expressing highly similar, stereotyped BcR IG. This discovery strongly suggests selection by common epitopes or classes of structurally similar epitopes in the development of these tumors. Initially observed in chronic lymphocytic leukemia (CLL), where the stereotyped fraction accounts for a substantial fraction of patients, stereotyped BcR IGs have also been identified in other mature B-cell malignancies, including mantle cell lymphoma (MCL) and splenic marginal zone lymphoma (SMZL). Further comparisons across different entities have indicated that stereotyped IGs are predominantly “disease-biased,” indicating distinct immune pathogenetic trajectories. Notably, accumulating evidence suggests that molecular subclassification of mature B-cell malignancies based on BcR IG stereotypy holds biological and clinical relevance. Particularly in CLL, patients belonging to the same subset due to the expression of a specific stereotyped BcR IG exhibit consistent biological backgrounds and clinical courses, especially for major and extensively studied subsets. Therefore, robust assignment to stereotyped subsets may aid in uncovering mechanisms underlying disease initiation and progression, as well as refining patient risk stratification. In this chapter, we offer an overview of recent studies on BcR IG stereotypy in mature B-cell malignancies and delineate past and present methodological approaches utilized for the identification of stereotyped BcR IG.Keywords
This publication has 122 references indexed in Scilit:
- VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 6‐YEAR RESULTS OF THE RANDOMIZED CLL14 STUDYHematological Oncology, 2023
- Disease‐biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferationsThe Journal of Pathology, 2018
- Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemiaInternational Journal of Cancer, 2018
- Molecular Evidence for Antigen Drive in the Natural History of Mantle Cell LymphomaThe American Journal of Pathology, 2015
- Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B‐cell receptor structure, function, and patients' prognosisAmerican Journal of Hematology, 2013
- IMGT® Tools for the Nucleotide Analysis of Immunoglobulin (IG) and T Cell Receptor (TR) V-(D)-J Repertoires, Polymorphisms, and IG Mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS2012
- Analysis of SF3B1 mutations in monoclonal B‐cell lymphocytosisHematological Oncology, 2012
- Length of the antibody heavy chain complementarity determining region 3 as a specificity‐determining factorJournal of Molecular Recognition, 2004
- Chronic B cell malignancies and bone marrow microenvironmentSeminars in Cancer Biology, 2002
- Performance evaluation of amino acid substitution matricesProteins: Structure, Function, and Bioinformatics, 1993